Acetyldigitoxin
Doxercalciferol may increase the arrhythmogenic activities of Acetyldigitoxin.
Aluminum Hydroxide
The serum concentration of Aluminum hydroxide can be increased when it is combined with Doxercalciferol.
aluminum hydroxide, dried (USP)
The serum concentration of Aluminum hydroxide can be increased when it is combined with Doxercalciferol.
Advertisement
Bendroflumethiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Bendroflumethiazide.
Calcifediol
The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcidiol.
Calcifediol Anhydrous
The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcidiol.
Advertisement
Calcipotriene
The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcipotriol.
Calcium Acetate
The risk or severity of adverse effects can be increased when Calcium Acetate is combined with Doxercalciferol.
Calcium Chloride
The risk or severity of adverse effects can be increased when Calcium Chloride is combined with Doxercalciferol.
Advertisement
Calcium Chloride Anhydrous
The risk or severity of adverse effects can be increased when Calcium Chloride is combined with Doxercalciferol.
Calcium Citrate
The risk or severity of adverse effects can be increased when Calcium Citrate is combined with Doxercalciferol.
Calcium Glubionate
The risk or severity of adverse effects can be increased when Calcium glubionate is combined with Doxercalciferol.
Calcium gluceptate
The risk or severity of adverse effects can be increased when Calcium Gluceptate is combined with Doxercalciferol.
Calcium Gluconate
The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Doxercalciferol.
Calcium Lactate
The risk or severity of adverse effects can be increased when Calcium lactate is combined with Doxercalciferol.
Casein Allergenic Extract
The risk or severity of adverse effects can be increased when Casein is combined with Doxercalciferol.
Chlorothiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Chlorothiazide.
Chlorthalidone
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Chlorthalidone.
Cholestyramine Resin
The serum concentration of Doxercalciferol can be decreased when it is combined with Cholestyramine.
Colesevelam
The serum concentration of Doxercalciferol can be decreased when it is combined with Colesevelam.
Colestipol
The serum concentration of Doxercalciferol can be decreased when it is combined with Colestipol.
Cyclopenthiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Cyclopenthiazide.
Danazol
Danazol may increase the hypercalcemic activities of Doxercalciferol.
Deslanoside
Doxercalciferol may increase the arrhythmogenic activities of Deslanoside.
Digitoxin
Doxercalciferol may increase the arrhythmogenic activities of Digitoxin.
Digoxin
Doxercalciferol may increase the arrhythmogenic activities of Digoxin.
Dihydrotachysterol
The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Dihydrotachysterol.
Ergocalciferol
The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Ergocalciferol.
Heavy mineral oil
The serum concentration of Doxercalciferol can be decreased when it is combined with Mineral oil.
Hydrochlorothiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Hydrochlorothiazide.
Hydroflumethiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Hydroflumethiazide.
Indapamide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Indapamide.
Methyclothiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Methyclothiazide.
Metolazone
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Metolazone.
Mineral Oil
The serum concentration of Doxercalciferol can be decreased when it is combined with Mineral oil.
Orlistat
The serum concentration of Doxercalciferol can be decreased when it is combined with Orlistat.
Ouabain
Doxercalciferol may increase the arrhythmogenic activities of Ouabain.
Ovine Digoxin Immune Fab
Doxercalciferol may increase the arrhythmogenic activities of Digoxin Immune Fab (Ovine).
Paricalcitol
The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Paricalcitol.
Polythiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Polythiazide.
Proscillaridin
Doxercalciferol may increase the arrhythmogenic activities of Proscillaridin.
Quinethazone
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Quinethazone.
Sucralfate
The serum concentration of Sucralfate can be increased when it is combined with Doxercalciferol.
Tricalcium Phosphate
The risk or severity of adverse effects can be increased when Calcium Phosphate is combined with Doxercalciferol.
Trichlormethiazide
The risk or severity of hyperkalemia can be increased when Doxercalciferol is combined with Trichlormethiazide.
